Other languages Gilead Sciences, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-03 pm EDT			5-day change	1st Jan Change
64.78 ^USD	-0.84%		-0.98%	-20.03%

May. 02	UBS Adjusts Price Target on Gilead Sciences to $70 From $75, Maintains Neutral Rating	MT
May. 01	Deutsche Bank Adjusts Price Target on Gilead Sciences to $73 From $75	MT

Hoge cashburn Galapagos	May. 03
Aandeelhouders Galapagos keuren alle agendapunten goed	May. 01
Gilead Sciences Receives FDA Approval for Updated Label of Biktarvy	Apr. 26
Alphabet : ExxonMobil, Microsoft...les valeurs à suivre aujourd'hui à Wall Street	Apr. 26
STATI UNITI. - I titoli da tenere d'occhio a Wall Street	Apr. 26
EE.UU. - Valores a seguir en Wall Street	Apr. 26
Gilead Sciences : dans le rouge au premier trimestre après ses acquisitions	Apr. 26
Gilead Sciences, Inc. Announces U.S. Food and Drug Administration Approve Biktarvy® Label Update With Data for Pregnant Adults With HIV	Apr. 26
En Direct des Marchés : TotalEnergies, Saint-Gobain, Safran, Airbus, Unibail, BHP, Microsoft, Alphabet...	Apr. 26
Gilead abaisse ses prévisions pour 2024 après plusieurs charges exceptionnelles	Apr. 25
Gilead Sciences Q1 Tops Estimates, Updates Outlook	Apr. 25
Gilead Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25
Gilead posts quarterly loss, revenue rises 5%	Apr. 25
Gilead Sciences, Inc. Revises Earnings Guidance for the Full Year 2024	Apr. 25
Gilead Sciences, Inc. Declares a Dividend for the Second Quarter of 2024, Payable on June 27, 2024	Apr. 25
US FDA mandates label updates on CAR-T cancer therapies	Apr. 18
WOCHENVORSCHAU: Termine bis 26. April 2024	Apr. 12
Nurix Therapeutics Announces Extension of Strategic Collaboration with Gilead Sciences	Apr. 02
Sector Update: Health Care Stocks Slide Late Afternoon	Apr. 01
Top Midday Gainers	Apr. 01

No results for this search